ANO1-downregulation induced by schisandrathera D: a novel therapeutic target for the treatment of prostate and oral cancers.
Park S, Das R, Nhiem NX, Jeong SB, Kim M, Kim D, Oh HI, Cho SH, Kwon OB, Choi JH, Park CS, Kim SR, Moon UY, Cha B, Choi DK, Lee S, Namkung W, Woo J, Seo Y.
Park S, et al. Among authors: nhiem nx.
Front Pharmacol. 2023 May 18;14:1163970. doi: 10.3389/fphar.2023.1163970. eCollection 2023.
Front Pharmacol. 2023.
PMID: 37274097
Free PMC article.